Does PRAVASTATIN Cause Malignant neoplasm progression? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with PRAVASTATIN (Pravastatin Sodium). This represents 0.1% of all adverse event reports for PRAVASTATIN.
5
Reports of Malignant neoplasm progression with PRAVASTATIN
0.1%
of all PRAVASTATIN reports
4
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PRAVASTATIN?
Of the 5 reports, 4 (80.0%) resulted in death, 4 (80.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PRAVASTATIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PRAVASTATIN Cause?
Myalgia (1,290)
Arthralgia (570)
Dyspnoea (514)
Fatigue (500)
Drug hypersensitivity (493)
Diarrhoea (478)
Headache (448)
Pruritus (432)
Nausea (420)
Dizziness (413)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PRAVASTATIN Alternatives Have Lower Malignant neoplasm progression Risk?
PRAVASTATIN vs PRAVASTATIN\PRAVASTATIN
PRAVASTATIN vs PRAZAXA
PRAVASTATIN vs PRAZEPAM
PRAVASTATIN vs PRAZIQUANTEL
PRAVASTATIN vs PRAZOSIN